Seminars in Nuclear Medicine
Volume 35, Issue 1 , Pages 52-61, January 2005

The role of myocardial perfusion imaging in special populations: Women, diabetics, and heart failure

  • Jennifer H. Mieres, MD

      Affiliations

    • Division of Cardiology, North Shore University Hospital, Manhasset, NY
    • Corresponding Author InformationAddress reprint requests to Jennifer H. Mieres, MD, FACC, Director of Nuclear Cardiology, Division of Cardiology, North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030
    • Corresponding Author InformationAddress reprint requests to Jennifer H. Mieres, MD, FACC, Director of Nuclear Cardiology, Division of Cardiology, North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030
  • ,
  • David R. Rosman, MD

      Affiliations

    • Division of Cardiology, North Shore University Hospital, Manhasset, NY
  • ,
  • Leslee J. Shaw, PhD

      Affiliations

    • Cedars-Sinai Medical Center, Los Angeles, CA

Cardiovascular disease and its manifestations remain a major worldwide public health problem. Despite significant advances in diagnosis and treatment, coronary artery disease remains the leading cause of death of men and women in the developed world. Early and accurate diagnosis of coronary artery disease is crucial if men and women are to have improved outcomes. The continuous and dramatic growth in the field of nuclear cardiology during the past 2 decades has accounted for its central role in the clinical evaluation of patients with known or suspected coronary heart disease. The development of electrocardiogram-gated single photon emission tomography has facilitated the expansion of nuclear cardiology studies from the evaluation of myocardial perfusion alone to the evaluation of both perfusion and ventricular function data in a single study. Myocardial perfusion imaging with electrocardiogram-gated single photon emission tomography, with its ability to provide information about the physiologic significance of coronary stenosis, left ventricular function, and risk assessment of patients with coronary artery disease, is ideally suited for the diagnostic and prognostic evaluation of the patient who is at high to intermediate risk for ischemic heart disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0001-2998(04)00063-7

doi:10.1053/j.semnuclmed.2004.09.004

Seminars in Nuclear Medicine
Volume 35, Issue 1 , Pages 52-61, January 2005